BioWorld

Feb. 27, 2008

Other News To Note

Clinic Roundup

CollaGenex Being Acquired by Galderma for $420M Cash

CollaGenex Pharmaceuticals Inc. said it has agreed to be acquired by a U.S. affiliate of Galderma Pharma SA for about $420 million. (BioWorld Today) Read More

Prana Shares Soar 60% on Positive Alzheimer's Data

Fake Dendritic Cell Expands T Cells Through Triple Action

ProMetic Partners with Kedrion on Plasma-Derived Proteins

Today's news in brief

BioWorld

BioWorld briefs for March 30, 2026.

Emerging therapeutic strategies for Parkinson’s at ADPD 2026

BioWorld

Parkinson’s disease (PD) involves the progressive loss of dopaminergic neurons, particularly in the substantia nigra. This neurodegeneration is linked to the...

Comparison of neurons in a healthy brain and nerve cells in neurodegenerative disease with amyloid plaques

Small-molecule TREM2 agonist advances to treat Alzheimer’s

BioWorld Science

Microglia play a central role in the neuroinflammation associated with Alzheimer’s disease (AD). These cells act as the brain’s immune system and respond to...

With improved technologies, biomarkers, failed drugs may come into their own

BioWorld

At BioEurope Spring 2026, pharma representatives and investors shared their thoughts about current and future landscapes of different disease areas, and on how to...

News in brief

BioWorld Asia

BioWorld Asia briefs for March 24, 2026